Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2025-12-28 @ 5:15 PM
Study NCT ID:
NCT04840992
Status:
COMPLETED
Last Update Posted:
2023-02-08
First Post:
2021-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation
Sponsor:
CanSino Biologics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-09
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-08
First Submit QC Date:
None
Study First Post Date:
2021-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-07
Last Update Post Date:
2023-02-08
Last Update Post Date Type:
ACTUAL